Immatics Biotechnologies
As of the edition of 20 October 2026, Immatics Biotechnologies runs 6 drugs.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Active | 1 |
| Went quiet | 1 |
| Stopped | 3 |
| Status not established | 1 |
| Total | 6 |
Where its trials are
- Cancer: 6 trials led
- Digestive system: 1 trials led
- Pregnancy and women's health: 1 trials led